Nov 08, 2017 13:00 pm UTC| Business
ST. MARYS, ANTIGUA, Nov. 08, 2017 -- Esports Entertainment Group, Inc. (OTCQB:GMBL) (or the "Company"), a licensed online gambling company with a specific focus on esports wagering and 18+ gaming, is pleased to announce...
Mesa Labs Acquires Sterilization and Disinfection Process Control Business
Nov 08, 2017 13:00 pm UTC| Business
LAKEWOOD, Colo., Nov. 08, 2017 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of substantially all of the assets and certain liabilities of BAG Health...
Petrogress, Inc. Forms Cypriot SPV to Operate Limassol Port Facility
Nov 08, 2017 13:00 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- Petrogress, Inc. (OTCMkts:PGAS) announced today that it has formed “PG Cypyard Offshore Service Terminal Ltd. (“Cypyard”) (Org. No. 529036) through Petrogress Int’l, LLC, its wholly owned...
American Health Council Names Adam G. Despres, BSN, RN to Nursing Board
Nov 08, 2017 13:00 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- Adam G. Despres, Registered Nurse at Hackettstown Regional Medical Center has been selected to join the Nursing Board at the American Health Council. He will be sharing his knowledge and...
Cambrex Invests in New Small Scale Capacity at Its Charles City, Iowa Facility
Nov 08, 2017 13:00 pm UTC| Business
EAST RUTHERFORD, NJ, Nov. 08, 2017 -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has completed an...
BioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28
Nov 08, 2017 13:00 pm UTC| Business
Santa Monica, CA, Nov. 08, 2017 -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the...
Proteon Therapeutics to Present at the Stifel 2017 Healthcare Conference November 15th
Nov 08, 2017 13:00 pm UTC| Business
WALTHAM, Mass., Nov. 08, 2017 -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...